能量代谢调控肠道干细胞功能研究进展及中医药治疗优势初探

doi:10.12114/j.issn.1007-9572.2023.0676

摘要/Abstract

摘要： 肠道干细胞是维持肠道屏障功能稳定的一个重要部分，与肠道稳态、肠道上皮更新、肠道损伤的修复密切相关。人体正常生理活动离不开能量的摄入与代谢，干细胞的分化命运受能量代谢的影响，且肠道屏障受损与多种肠道疾病的发生发展有关。故本文以肠道干细胞为中心，以能量代谢及代谢物为背景，探究能量代谢及代谢物如何调控干细胞功能和活性，从而调节肠道屏障功能，为多种肠道疾病的治疗提供思路；此外，随着现代医学在保护肠道屏障方面研究的深入，中医讲求"顾护脾胃"的理论逐渐显示出科学性，以期为后续的研究提供思路。

关键词: 肠道干细胞, 能量代谢, 肠道疾病, 中医药, 综述

Abstract:

Intestinal stem cells are an important part of maintaining the stability of intestinal barrier function, which is closely related to intestinal homeostasis, intestinal epithelial renewal, and repair of intestinal damage. Normal physiological activities of the human body cannot be separated from energy intake and metabolism, and the differentiation fate of stem cells is affected by energy metabolism, and impaired intestinal barrier is associated with the development of many intestinal diseases. Therefore, this paper focuses on intestinal stem cells, takes energy metabolism and metabolites as the background to investigate how energy metabolism and metabolites regulate the function and activity of stem cells, thus regulating the function of intestinal barrier and providing ideas for the treatment of various intestinal diseases; in addition, with the in-depth research of modern medical science in protecting intestinal barrier, the theory of traditional Chinese medicine (TCM) that cares for spleen and stomach is gradually showing its scientific validity, with the hope of providing ideas for the subsequent research.

Key words: Intestinal stem cells, Energy metabolism, Intestinal diseases, Traditional Chinese medicine, Review

朱焰,肖瑾,杨阳,等. 能量代谢调控肠道干细胞功能研究进展及中医药治疗优势初探[J]. 中国全科医学, 2024, 27(23): 2853-2857. DOI: 10.12114/j.issn.1007-9572.2023.0676.
ZHU Yan,XIAO Jin,YANG Yang, et al. Advances in Energy Metabolism Regulation of Intestinal Stem Cell Function and the Therapeutic Advantages of Traditional Chinese Medicine[J]. Chinese General Practice, 2024, 27(23): 2853-2857. DOI: 10.12114/j.issn.1007-9572.2023.0676.

参考文献 42

[1]	LINSALATA M，RIEZZO G，ORLANDO A，et al. The relationship between low serum vitamin D levels and altered intestinal barrier function in patients with IBS diarrhoea undergoing a long-term low-FODMAP diet：novel observations from a clinical trial[J]. Nutrients，2021，13（3）：1011. DOI：10.3390/nu13031011.
[2]	MEHANDRU S，COLOMBEL J F. The intestinal barrier，an arbitrator turned provocateur in IBD[J]. Nat Rev Gastroenterol Hepatol，2021，18（2）：83-84. DOI：10.1038/s41575-020-00399-w.
[3]	JANNEY A，POWRIE F，MANN E H. Host-microbiota maladaptation in colorectal cancer[J]. Nature，2020，585（7826）：509-517. DOI：10.1038/s41586-020-2729-3.
[4]	CAMARA-LEMARROY C R，METZ L，MEDDINGS J B，et al. The intestinal barrier in multiple sclerosis：implications for pathophysiology and therapeutics[J]. Brain，2018，141（7）：1900-1916. DOI：10.1093/brain/awy131.
[5]	LEWIS C V，TAYLOR W R. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease[J]. Am J Physiol Heart Circ Physiol，2020，319（6）：H1227-1233. DOI：10.1152/ajpheart.00612.2020.
[6]	AN J，LIU Y Q，WANG Y Q，et al. The role of intestinal mucosal barrier in autoimmune disease：a potential target[J]. Front Immunol，2022，13：871713. DOI：10.3389/fimmu.2022.871713.
[7]	GEHART H，CLEVERS H. Tales from the crypt：new insights into intestinal stem cells[J]. Nat Rev Gastroenterol Hepatol，2019，16（1）：19-34. DOI：10.1038/s41575-018-0081-y.
[8]	ISHIKAWA K，SUGIMOTO S，ODA M，et al. Identification of quiescent LGR5+ stem cells in the human colon[J]. Gastroenterology，2022，163（5）：1391-1406.e24. DOI：10.1053/j.gastro.2022.07.081.
[9]	LEUNG C，TAN S H，BARKER N. Recent advances in Lgr5+ stem cell research[J]. Trends Cell Biol，2018，28（5）：380-391. DOI：10.1016/j.tcb.2018.01.010.
[10]	CHEN L，VASOYA R P，TOKE N H，et al. HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice[J]. Gastroenterology，2020，158（4）：985-999.e9. DOI：10.1053/j.gastro.2019.11.031.
[11]	GUNN D，GARSED K，LAM C，et al. Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron[J]. Aliment Pharmacol Ther，2019，50（5）：538-546. DOI：10.1111/apt.15420.
[12]	段睿潇，赵一帆，叶永娟，等. 胆汁酸代谢调节炎症性肠病的作用机制及药物研发[J]. 中国临床药理学与治疗学，2022，27（10）：1171-1181. DOI：10.12092/j.issn.1009-2501.2022.10.012.
[13]	李春静，马玉侠. 基于代谢组学的隔药灸脐法治疗脾虚型肠易激综合征机制研究[J]. 中华中医药杂志，2019，34（7）：2969-2972.
[14]	DONG L N，WANG M，GUO J，et al. Role of intestinal microbiota and metabolites in inflammatory bowel disease[J]. Chin Med J，2019，132（13）：1610-1614. DOI：10.1097/CM9.0000000000000290.
[15]	BEYAZ S，MANA M D，ROPER J，et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors[J]. Nature，2016，531（7592）：53-58. DOI：10.1038/nature17173.
[16]	HOY A J，NAGARAJAN S R，BUTLER L M. Tumour fatty acid metabolism in the context of therapy resistance and obesity[J]. Nat Rev Cancer，2021，21（12）：753-766. DOI：10.1038/s41568-021-00388-4.
[17]	FU T，COULTER S，YOSHIHARA E，et al. FXR regulates intestinal cancer stem cell proliferation[J]. Cell，2019，176（5）：1098-1112.e18. DOI：10.1016/j.cell.2019.01.036.
[18]	PERINO A，DEMAGNY H，VELAZQUEZ-VILLEGAS L，et al. Molecular physiology of bile acid signaling in health，disease，and aging[J]. Physiol Rev，2021，101（2）：683-731. DOI：10.1152/physrev.00049.2019.
[19]	SORRENTINO G，PERINO A，YILDIZ E，et al. Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration[J]. Gastroenterology，2020，159（3）：956-968.e8. DOI：10.1053/j.gastro.2020.05.067.
[20]	CHEN L，JIAO T Y，LIU W W，et al. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal[J]. Cell Stem Cell，2022，29（9）：1366-1381.e9. DOI：10.1016/j.stem.2022.08.008.
[21]	LI X L，YANG Y Y，ZHANG B，et al. Lactate metabolism in human health and disease[J]. Signal Transduct Target Ther，2022，7（1）：305. DOI：10.1038/s41392-022-01151-3.
[22]	RABINOWITZ J D，ENERBÄCK S. Lactate：the ugly duckling of energy metabolism[J]. Nat Metab，2020，2（7）：566-571. DOI：10.1038/s42255-020-0243-4.
[23]	LEE Y S，KIM T Y，KIM Y，et al. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development[J]. Cell Host Microbe，2018，24（6）：833-846.e6. DOI：10.1016/j.chom.2018.11.002.
[24]	LIU X，HODGSON J J，BUCHON N. Drosophila as a model for homeostatic，antibacterial，and antiviral mechanisms in the gut[J]. PLoS Pathog，2017，13（5）：e1006277. DOI：10.1371/journal.ppat.1006277.
[25]	IATSENKO I，BOQUETE J P，LEMAITRE B. Microbiota-derived lactate activates production of reactive oxygen species by the intestinal NADPH oxidase nox and shortens Drosophila lifespan[J]. Immunity，2018，49（5）：929-942.e5. DOI：10.1016/j.immuni.2018.09.017.
[26]	ZHANG H B，MENZIES K J，AUWERX J. The role of mitochondria in stem cell fate and aging[J]. Development，2018，145（8）：dev143420. DOI：10.1242/dev.143420.
[27]	LUDIKHUIZE M C，MEERLO M，GALLEGO M P，et al. Mitochondria define intestinal stem cell differentiation downstream of a FOXO/notch axis[J]. Cell Metab，2020，32（5）：889-900.e7. DOI：10.1016/j.cmet.2020.10.005.
[28]	SONG I S，JEONG Y J，JEONG S H，et al. FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function[J]. Gastroenterology，2015，149（4）：1006-1016.e9. DOI：10.1053/j.gastro.2015.06.007.
[29]	RATH E，MOSCHETTA A，HALLER D. Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis[J]. Nat Rev Gastroenterol Hepatol，2018，15（8）：497-516. DOI：10.1038/s41575-018-0021-x.
[30]	BENSARD C L，WISIDAGAMA D R，OLSON K A，et al. Regulation of tumor initiation by the mitochondrial pyruvate carrier[J]. Cell Metab，2020，31（2）：284-300.e7. DOI：10.1016/j.cmet.2019.11.002.
[31]	SCHELL J C，WISIDAGAMA D R，BENSARD C，et al. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism[J]. Nat Cell Biol，2017，19（9）：1027-1036. DOI：10.1038/ncb3593.
[32]	马向明，曹立瀛. 恶性肿瘤线粒体丙酮酸代谢障碍研究进展[J]. 中华肿瘤防治杂志，2019，26（3）：199-204. DOI：10.16073/j.cnki.cjcpt.2019.03.012.
[33]	韩睿盈，姜志深，高灿宇，等. 常见肠道菌群代谢产物作为疾病诊断的指针的研究进展[J]. 微生物学通报，2021，48（11）：4261-4274. DOI：10.13344/j.microbiol.china.210071.
[34]	LIU N，SUN S Q，WANG P J，et al. The mechanism of secretion and metabolism of gut-derived 5-hydroxytryptamine[J]. Int J Mol Sci，2021，22（15）：7931. DOI：10.3390/ijms22157931.
[35]	MARKANDEY M，BAJAJ A，ILOTT N E，et al. Gut microbiota：sculptors of the intestinal stem cell niche in health and inflammatory bowel disease[J]. Gut Microbes，2021，13（1）：1990827. DOI：10.1080/19490976.2021.1990827.
[36]	XING P Y，PETTERSSON S，KUNDU P. Microbial metabolites and intestinal stem cells tune intestinal homeostasis[J]. Proteomics，2020，20（5/6）：e1800419. DOI：10.1002/pmic.201800419.
[37]	ZHU P P，LU T K，WU J Y，et al. Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons[J]. Cell Res，2022，32（6）：555-569. DOI：10.1038/s41422-022-00645-7.
[38]	李青青，刘建昆，潘兴华. 干细胞移植治疗炎症性肠病[J]. 中国组织工程研究，2017，21（21）：3432-3437. DOI：10.3969/j.issn.2095-4344.2017.21.025.
[39]	VILLABLANCA E J，SELIN K，HEDIN C R H. Mechanisms of mucosal healing：treating inflammatory bowel disease without immunosuppression?[J]. Nat Rev Gastroenterol Hepatol，2022，19（8）：493-507. DOI：10.1038/s41575-022-00604-y.
[40]	PU Z N，YANG F，WANG L，et al. Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer[J]. J Drug Target，2021，29（5）：507-519. DOI：10.1080/1061186X.2020.1864741.
[41]	ZHAO Y X，LUAN H F，GAO H，et al. Gegen Qinlian Decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling[J]. Phytomedicine，2020，68：153182. DOI：10.1016/j.phymed.2020.153182.
[42]	LIN J C，WU J Q，WANG F，et al. QingBai Decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of Notch and NF-κB signalling[J]. Cell Prolif，2019，52（2）：e12547. DOI：10.1111/cpr.12547.